Robot-assisted surgery continues to generate headlines in the orthopedics space. But there is so much more going on among the world’s largest orthopedic device companies.
10. ConMed – Orthopedic Surgery
2018 revenue: $446.7 million
ConMed (NSDQ:CNMD) saw its domestic orthopedics revenue grow 4.5% in 2018, and international orthopedics revenue increased 3.5% year-over-year. Orthopedic products generating excitement at the Utica, N.Y.–based company include its MicroFree cordless small-bone power system, CEO Todd Garner said during a January earnings call transcribed by Seeking Alpha.
The MicroFree cordless, battery-powered, pencil-grip instruments for small bone are meant to provide the freedom of cordless for ortho surgeons while still delivering the necessary power.
9. Orthofix Medical
2018 revenue: $453.0 million
Orthofix Medical stock (NSDQ:OFIX) fell by nearly a fifth in value in late February and early March after the Lewisville, Texas–based company failed to meet Wall Street analysts’ expectations for its fourth-quarter and 2018 sales.
The company had some good news this week, however. An Investigational Device Exemption device study of its M6-C artificial cervical disc showed a significant improvement in neck and arm pain, function and quality of life scores. The FDA used the study results in making its decision to approve the M6-C, which has been available in the E.U. and other countries since 2006.
8. Wright Medical
2018 revenue: $836.2 million
Wright Medical (NSDQ:WMGI) used the American Academy of Orthopaedic Surgeons (AAOS) show in Las Vegas last month to tout its Revive revision shoulder system. The Revive system includes specialized extraction instruments for implant removal and a unique humeral prosthesis for joint reconstruction. Amsterdam-based Wright plans a U.S. launch of Revive in first half of this year.
Image Credit: Unsplash